Insights into the Mechanism of Oral Tolerance Derived from the Study of Models of Mucosal Inflammation
- 1 December 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1029 (1) , 115-131
- https://doi.org/10.1196/annals.1309.029
Abstract
Murine models of mucosal inflammation are frequently due to the inability of the mouse to mount a regulatory T cell response. To the extent that such responses arise from oral tolerance mechanisms, these models provide a unique way of studying oral tolerance. In this paper we focus on the regulatory cells generated in two of the most well-studied of such models, the cell-transfer model and the TNBS-colitis model. Our analysis leads to the view that regulatory cells generated by the oral tolerance seen in mucosal inflammation are, at least in part, cells that recognize self-antigens or antigens in the mucosal microflora whose effector function relies on the expression of TGF-beta.Keywords
This publication has 38 references indexed in Scilit:
- Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal BacteriaScience, 2004
- Transforming Growth Factor (TGF)-β1–producing Regulatory T Cells Induce Smad-mediated Interleukin 10 Secretion That Facilitates Coordinated Immunoregulatory Activity and Amelioration of TGF-β1–mediated FibrosisThe Journal of Experimental Medicine, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent MechanismsThe Journal of Experimental Medicine, 2003
- CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and ResponsivenessThe Journal of Experimental Medicine, 2002
- Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor βThe Journal of Experimental Medicine, 2001
- Treatment of Experimental (Trinitrobenzene Sulfonic Acid) Colitis by Intranasal Administration of Transforming Growth Factor (Tgf)-β1 PlasmidThe Journal of Experimental Medicine, 2000
- Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion.The Journal of Experimental Medicine, 1996
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.The Journal of Experimental Medicine, 1994